Advanced Liver Disease (Stages 4–5): Complications, Prognosis & Transplant

Stages 4–5 represent decompensated cirrhosis (Child‑Pugh B/C) with life‑threatening complications.

Stage 4: Advanced Fibrosis / Compensated Cirrhosis

• Extensive bridging fibrosis / cirrhosis; liver synthetic function preserved.
• May be asymptomatic or have mild fatigue, spider angiomata, palmar erythema.
• Portal hypertension develops: varices, splenomegaly, thrombocytopenia.
• Surveillance: endoscopy for varices, ultrasound for HCC q6mo.

Stage 5: Decompensated Cirrhosis / End‑Stage Liver Disease

Defining complications:

• Ascites: refractory in 10%; SBP risk.
• Variceal hemorrhage: 15–20% annual risk if large varices.
• Hepatic encephalopathy: graded I–IV; precipitated by infection, GI bleed, electrolytes, sedatives.
• Jaundice: bilirubin >2–3 mg/dL.
• Hepatorenal syndrome (HRS‑AKI): functional renal failure; high mortality.
• Hepatopulmonary syndrome / portopulmonary hypertension.
• Coagulopathy, immune dysfunction.

Prognosis

• Child‑Pugh C: median survival 1–3 months without transplant.
• MELD‑Na ≥25: 3‑month mortality >50%.
• ACLF (organ failures): 28‑day mortality 30–80% by grade.

Management Priorities

1. Transplant evaluation: only curative option; refer early (MELD ≥15).
2. Complication control: diuretics, NSBB, lactulose/rifaximin, antibiotics for SBP prophylaxis, terlipressin/albumin for HRS.
3. Nutrition: 35–40 kcal/kg, 1.2–1.5 g/kg protein; late‑evening snack.
4. Abstinence: alcohol cessation improves survival even in advanced disease.
5. Palliative care: symptom management, goals‑of‑care discussions.